Market by Product (Consumables, Instruments, Imagers) Application (Biomedical & Biochemical Research, Disease Diagnostics, Agriculture, Other Applications) End-user (Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Centers, Other End-users) and Country Outlook | Forecast 2024-2032
As per Triton’s research report, the western blotting market in the Asia-Pacific is estimated to expand in terms of revenue at a CAGR of 6.68% during the forecast period 2024-2032.
Report scope can be customized per your requirements - Request Free Sample Report
As per UNAIDS, an estimated 6.7 million people in Asia and the Pacific are living with HIV as of 2023. The growing prevalence of HIV and Hepatitis B in this region, coupled with underdiagnosis due to a lack of clear diagnostic criteria and treatment guidelines, is expected to drive demand for more reliable and accurate diagnostic methods. Western blotting, a widely recognized technique for confirming the presence of viral infections like HIV and Hepatitis B, will likely see increased usage as healthcare providers aim to improve detection rates. As more people are tested and diagnosed, the need for confirmatory tests like western blotting will rise, contributing to market growth in the region.
The countries analyzed in this region include:
China leads with a major market share, recording nearly $53.67 million in 2023.
In recent years, the number of people living with HIV in China has exceeded 1.05 million, with high-risk groups such people who inject drugs remaining the most affected.
The rise in HIV cases, particularly among high-risk groups and younger populations in the country, has led to a growing demand for accurate and reliable diagnostic methods with an added reliance on confirmatory testing methods like western blotting.
This technique is also utilized in research settings to understand the nature of HIV, develop new treatment methods, and monitor patients’ responses to antiretroviral therapies.
China’s commitment to funding its HIV response from domestic sources supports investments in diagnostic technologies, contributing to the growth of the western blotting market.
Western Blotting Market Forecast for Japan The growth of the western blotting market in Japan is influenced by various factors, including the increasing prevalence of chronic diseases, government support for biomedical and biotechnology industries, and expanding research activities in molecular biology, proteomics, and drug discovery. Japan, along with other countries in the Asia-Pacific region, is witnessing a surge in the adoption of western blotting techniques due to growing investment in the pharmaceutical and biotechnology sectors, supported by government funding and initiatives.
The western blotting market is segmented by product, application, and end-user. Based on application, it is further classified into disease diagnostics, agriculture, biomedical & biochemical research, and other applications. The western blotting techniques find its application in the disease diagnostics segment for detecting HIV, autoimmune disorders, and cancer. Technological advancements, rising chronic disease prevalence, and the adoption of multiplexing technologies drive its demand in clinical laboratories.
Contender Analysis in the Western Blotting Market:
Thermo Fisher Scientific Inc is a leading manufacturer of scientific instruments, chemicals, and consumables. The company provides a range of products and services, including analytical instruments, laboratory equipment, software, reagents, and consumables, to industries such as pharmaceuticals, hospitals, biotech, research institutions, and government agencies. Its Specialty Diagnostics segment focuses on delivering immunodiagnostic reagent kits, blood-test systems for diagnosing allergies, asthma, and autoimmune diseases, as well as products for cancer research and medical diagnostics. It is headquartered in Massachusetts, US.
In August 2024, The FDA approved Thermo Fisher Scientific’s SeCore HLA Typing Kit for use as a companion diagnostic with a T-cell receptor therapy to treat synovial sarcoma.
Other key contenders in the market include Bio-Techne Corporation, Cell Signaling Technology Inc, Li-Cor Inc, Advansta Inc, and Lumigen Inc.
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the western blotting market revenue growth in APAC and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the APAC western blotting market’s growth during the upcoming years
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
WESTERN BLOTTING MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE WESTERN BLOTTING MARKET
2.1.1. COVID-19
IMPACT ON THE WESTERN BLOTTING MARKET
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. KEY
MARKET STRATEGIES
2.3.1. PRODUCT
LAUNCHES
2.3.2. ACQUISITIONS
2.3.3. BUSINESS
EXPANSIONS
2.4. MARKET
DRIVERS
2.4.1. HIGH
DEMAND FOR PROTEOMICS
2.4.2. RISE
IN APPLICATIONS FOR WESTERN BLOTTING
2.4.3. GROWING
OCCURRENCE OF HIV AND LYME DISEASE
2.5. MARKET
CHALLENGES
2.5.1. ADVANCEMENTS
IN SUBSTITUTE TECHNOLOGIES
2.5.2. ELEVATED
ANTIBODY COSTS
2.5.3. REQUIREMENT
FOR IMPROVED PROCEDURAL EFFICIENCY TO ACHIEVE PRECISION
2.6. MARKET
OPPORTUNITIES
2.6.1. RISING
INTEREST IN TAILORED MEDICINE
2.6.2. WESTERN
BLOT INSTRUMENT AUTOMATION
2.6.3. PROGRESS
IN TECHNOLOGICAL ADVANCEMENTS
2.7. ANALYST
PERSPECTIVE
3. ASIA-PACIFIC
WESTERN BLOTTING MARKET – BY PRODUCT
3.1. CONSUMABLES
3.1.1. REAGENTS
AND BUFFERS
3.1.2. KITS
3.1.3. OTHER
CONSUMABLES
3.2. INSTRUMENTS
3.2.1. GEL
ELECTROPHORESIS INSTRUMENTS
3.2.2. BLOTTING
SYSTEMS
3.2.2.1. DRY
BLOTTING SYSTEMS
3.2.2.2. SEMI-DRY
BLOTTING SYSTEMS
3.2.2.3. WET
BLOTTING SYSTEMS
3.2.3. IMAGERS
3.2.3.1. CHEMILUMINESCENT
IMAGERS
3.2.3.2. FLUORESCENT
IMAGERS
3.2.3.3. OTHER
IMAGERS
4. ASIA-PACIFIC
WESTERN BLOTTING MARKET – BY APPLICATION
4.1. BIOMEDICAL
& BIOCHEMICAL RESEARCH
4.2. DISEASE
DIAGNOSTICS
4.3. AGRICULTURE
4.4. OTHER
APPLICATIONS
5. ASIA-PACIFIC
WESTERN BLOTTING MARKET – BY END-USER
5.1. RESEARCH
INSTITUTES
5.2. PHARMACEUTICAL
& BIOTECHNOLOGY COMPANIES
5.3. DIAGNOSTIC
CENTERS
5.4. OTHER
END-USERS
6. ASIA-PACIFIC
WESTERN BLOTTING MARKET – BY COUNTRY OUTLOOK
6.1. ASIA-PACIFIC
6.1.1. COUNTRY
ANALYSIS
6.1.1.1. CHINA
6.1.1.1.1. CHINA WESTERN
BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.2. JAPAN
6.1.1.2.1. JAPAN WESTERN
BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.3. INDIA
6.1.1.3.1. INDIA WESTERN
BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.4. SOUTH
KOREA
6.1.1.4.1. SOUTH
KOREA WESTERN BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.5. ASEAN
COUNTRIES
6.1.1.5.1. ASEAN
COUNTRIES WESTERN BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.6. AUSTRALIA
& NEW ZEALAND
6.1.1.6.1. AUSTRALIA
& NEW ZEALAND WESTERN BLOTTING MARKET FORECAST & PROSPECTS
6.1.1.7. REST
OF ASIA-PACIFIC
6.1.1.7.1. REST
OF ASIA-PACIFIC WESTERN BLOTTING MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1. MERCK
KGAA
7.1.1. OVERVIEW
7.1.2. PORTFOLIO
7.1.3. KEY
STRENGTHS
7.1.4. KEY
CHALLENGES
7.2. THERMO
FISHER SCIENTIFIC
7.2.1. OVERVIEW
7.2.2. PORTFOLIO
7.2.3. KEY
STRENGTHS
7.2.4. KEY
CHALLENGES
7.3. BIO-RAD
TECHNOLOGIES
7.3.1. OVERVIEW
7.3.2. PORTFOLIO
7.3.3. KEY
STRENGTHS
7.3.4. KEY
CHALLENGES
7.4. BIO-TECHNE
CORPORATION
7.4.1. OVERVIEW
7.4.2. PORTFOLIO
7.4.3. KEY
STRENGTHS
7.4.4. KEY
CHALLENGES
7.5. CELL
SIGNALING TECHNOLOGY
7.5.1. OVERVIEW
7.5.2. PORTFOLIO
7.5.3. KEY
STRENGTHS
7.5.4. KEY
CHALLENGES
7.6. LI-COR
INC
7.6.1. OVERVIEW
7.6.2. PORTFOLIO
7.6.3. KEY
STRENGTHS
7.6.4. KEY
CHALLENGES
7.7. ADVANSTA
INC
7.7.1. OVERVIEW
7.7.2. PORTFOLIO
7.7.3. KEY
STRENGTHS
7.7.4. KEY
CHALLENGES
7.8. AZURE
BIOSYSTEMS INC
7.8.1. OVERVIEW
7.8.2. PORTFOLIO
7.8.3. KEY
STRENGTHS
7.8.4. KEY
CHALLENGES
7.9. PERKINELEMER
INC
7.9.1. OVERVIEW
7.9.2. PORTFOLIO
7.9.3. KEY
STRENGTHS
7.9.4. KEY
CHALLENGES
7.10. LUMIGEN
INC
7.10.1. OVERVIEW
7.10.2. PORTFOLIO
7.10.3. KEY
STRENGTHS
7.10.4. KEY CHALLENGES
7.11. ROCKLAND
IMMUNOCHEMICALS INC
7.11.1. OVERVIEW
7.11.2. PORTFOLIO
7.11.3. KEY
STRENGTHS
7.11.4. KEY
CHALLENGES
7.12. ENZO
BIOCHEM INC
7.12.1. COMPANY
OVERVIEW
7.12.2. PORTFOLIO
7.12.3. KEY
STRENGTHS
7.12.4. KEY
CHALLENGES
7.13. GENO
TECHNOLOGY INC
7.13.1. COMPANY
OVERVIEW
7.13.2. PORTFOLIO
7.13.3. KEY
STRENGTHS
7.13.4. KEY
CHALLENGES
7.14. STRESSMARQ
BIOSCIENCES INC
7.14.1. COMPANY
OVERVIEW
7.14.2. PORTFOLIO
7.14.3. KEY
STRENGTHS
7.14.4. KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 2: LIST OF PRODUCT
LAUNCHES
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF BUSINESS
EXPANSIONS
TABLE 5: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY CONSUMABLES, 2024-2032 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY INSTRUMENTS, 2024-2032 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY BLOTTING SYSTEMS, 2024-2032, (IN $ MILLION)
TABLE 9: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY IMAGERS, 2024-2032, (IN $ MILLION)
TABLE 10: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY END-USER, 2024-2032 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY PRODUCT, 2023 & 2032 (IN %)
FIGURE 3: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY CONSUMABLES, 2024-2032 (IN $ MILLION)
FIGURE 4: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY CONSUMABLES, 2023 & 2032 (IN %)
FIGURE 5: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY REAGENTS AND BUFFERS, 2024-2032 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY KITS, 2023 & 2032 (IN %)
FIGURE 7: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY OTHER CONSUMABLES, 2024-2032 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY INSTRUMENTS, 2023 & 2032 (IN %)
FIGURE 9: ASIA-PACIFIC WESTERN
BLOTTING MARKET, BY GEL ELECTROPHORESIS INSTRUMENTS, 2024-2032 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY BLOTTING SYSTEMS, 2023 & 2032 (IN %)
FIGURE 12: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY DRY BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY SEMI-DRY BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY WET BLOTTING SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY IMAGERS, 2023 & 2032 (IN %)
FIGURE 16: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY CHEMILUMINESCENT IMAGERS, 2024-2032 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY FLUORESCENT IMAGERS, 2024-2032 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY OTHER IMAGERS, 2024-2032 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY APPLICATION, 2023 & 2032 (IN %)
FIGURE 20: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY BIOMEDICAL & BIOCHEMICAL RESEARCH, 2024-2032
(IN $ MILLION)
FIGURE 21: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY DISEASE DIAGNOSTICS, 2024-2032 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY AGRICULTURE, 2024-2032 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY END-USER, 2023 & 2032 (IN %)
FIGURE 25: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY RESEARCH INSTITUTES, 2024-2032 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,
2024-2032 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY OTHER END-USERS, 2024-2032 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC
WESTERN BLOTTING MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 30: CHINA WESTERN
BLOTTING MARKET 2024-2032 (IN $ MILLION)
FIGURE 31: JAPAN WESTERN
BLOTTING MARKET 2024-2032 (IN $ MILLION)
FIGURE 32: INDIA WESTERN
BLOTTING MARKET 2024-2032 (IN $ MILLION)
FIGURE 33: SOUTH KOREA WESTERN
BLOTTING MARKET 2024-2032 (IN $ MILLION)
FIGURE 34: ASEAN COUNTRIES
WESTERN BLOTTING MARKET 2024-2032 (IN $ MILLION)
FIGURE 35: AUSTRALIA & NEW
ZEALAND WESTERN BLOTTING MARKET 2024-2032 (IN $ MILLION)
FIGURE 36: REST OF
ASIA-PACIFIC WESTERN BLOTTING MARKET 2024-2032 (IN $ MILLION)